EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential

Youcef M Rustum, Aseel O. Rataan, Yousef Zakharia, Marco Davila, Obed B. Amissah, Gloria B. Kim

Medical Research Archives · 07.07.2026 · 14 (6)

DOI: 10.18103/mra.2026.0326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 07.07.2026. Verfasst von Youcef M Rustum und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TGF-?1, a multifunctional cytokine ubiquitously overexpressed in advanced cancers, is a critical target implicated in drug resistance, immune evasion, increased tumor angiogenesis, and unstable TME. We discovered for the first time that pharmacologic doses of SLM and AA are potent in vivo selective inhibitors of TGF-?1. Inhibition of TGF-?1 was associated with time-dependent inhibition of HIFs, PD-L1, VEGF, CAR-T cell activation, activation of TET by AA, inhibition of DNMTs by SLM, stabilization of tumor vasculature, increased drug delivery to tumor cells, and enhanced efficacy of oncolytic agents. The pleiotropic effects induced by pharmacologic doses and schedule of SLM offer the potential for enhancing the therapeutic efficacy of immunotherapy in cancer patients.

Zitieren

APA

Rustum, Y. M., Rataan, A. O., Zakharia, Y., Davila, M., Amissah, O. B., & Kim, G. B. (2026). Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential. Medical Research Archives, 14(6). https://doi.org/10.18103/mra.2026.0326

Vancouver

Rustum YM, Rataan AO, Zakharia Y, Davila M, Amissah OB, Kim GB. Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential. Medical Research Archives. 2026;14(6). doi:10.18103/mra.2026.0326

BibTeX
@article{Rustum2026,
  author = {Rustum, Youcef M and Rataan, Aseel O. and Zakharia, Yousef and Davila, Marco and Amissah, Obed B. and Kim, Gloria B.},
  title = {Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential},
  journal = {Medical Research Archives},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.18103/mra.2026.0326}
}
Kostenlos starten →